{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T10:42:01Z","timestamp":1794566521166,"version":"4.9.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,18]],"date-time":"2017-09-18T00:00:00Z","timestamp":1505692800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jaacap.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Child &amp; Adolescent Psychiatry"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.jaac.2017.09.414","type":"journal-article","created":{"date-parts":[[2017,9,19]],"date-time":"2017-09-19T18:15:24Z","timestamp":1505844924000},"page":"948-957.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":292,"title":["Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children With Autism Spectrum Disorder"],"prefix":"10.1016","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0495-3517","authenticated-orcid":false,"given":"Paul","family":"Gringras","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tali","family":"Nir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Breddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anat","family":"Frydman-Marom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L.","family":"Findling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaac.2017.09.414_bib1","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.pediatrneurol.2012.05.007","article-title":"Sleep in children with autism spectrum disorder","volume":"47","author":"Kotagal","year":"2012","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.jaac.2017.09.414_bib2","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/DBP.0000000000000140","article-title":"Sleep differences among children with autism spectrum disorders and typically developing peers: a meta-analysis","volume":"36","author":"Elrod","year":"2015","journal-title":"J\u00a0Dev Behav Pediatr"},{"key":"10.1016\/j.jaac.2017.09.414_bib3","series-title":"Diagnostic and Statistical Manual of Mental Disorders DSM-5","year":"2013"},{"key":"10.1016\/j.jaac.2017.09.414_bib4","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1017\/S001216220600137X","article-title":"Sleep problems of children with pervasive developmental disorders: correlation with parental stress","volume":"48","author":"Doo","year":"2006","journal-title":"Dev Med Child Neurol"},{"issue":"Suppl 2","key":"10.1016\/j.jaac.2017.09.414_bib5","doi-asserted-by":"crossref","first-page":"S106","DOI":"10.1542\/peds.2012-0900I","article-title":"A\u00a0practice pathway for the identification, evaluation, and management of insomnia in children and adolescents with autism spectrum disorders","volume":"130","author":"Malow","year":"2012","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaac.2017.09.414_bib6","doi-asserted-by":"crossref","first-page":"e6664","DOI":"10.1136\/bmj.e6664","article-title":"Melatonin for sleep problems in children with neurodevelopmental disorders: randomised double masked placebo controlled trial","volume":"345","author":"Gringras","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.jaac.2017.09.414_bib7","doi-asserted-by":"crossref","first-page":"e1223","DOI":"10.1542\/peds.2005-1693","article-title":"Pharmacologic management of insomnia in children and adolescents: consensus statement","volume":"117","author":"Mindell","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaac.2017.09.414_bib8","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.ridd.2010.12.035","article-title":"Pharmacological treatment of sleep disturbance in developmental disabilities: a review of the literature","volume":"32","author":"Hollway","year":"2011","journal-title":"Res Dev Disabil"},{"key":"10.1016\/j.jaac.2017.09.414_bib9","doi-asserted-by":"crossref","first-page":"275","DOI":"10.5664\/jcsm.6462","article-title":"Melatonin natural health products and supplements: presence of serotonin and significant variability of melatonin content","volume":"13","author":"Erland","year":"2017","journal-title":"J\u00a0Clin Sleep Med"},{"key":"10.1016\/j.jaac.2017.09.414_bib10","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1365-2265.1988.tb00263.x","article-title":"Melatonin","volume":"29","author":"Arendt","year":"1988","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jaac.2017.09.414_bib11","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.biopsych.2004.11.003","article-title":"Nocturnal excretion of 6-sulphatoxymelatonin in children and adolescents with autistic disorder","volume":"57","author":"Tordjman","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.jaac.2017.09.414_bib12","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1469-8749.2011.03980.x","article-title":"Melatonin in autism spectrum disorders: a systematic review and meta-analysis","volume":"53","author":"Rossignol","year":"2011","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.jaac.2017.09.414_bib13","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.tem.2006.07.007","article-title":"Inverted rhythm of melatonin secretion in Smith-Magenis syndrome: from symptoms to treatment","volume":"17","author":"De Leersnyder","year":"2006","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.jaac.2017.09.414_bib14","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/phar.1920","article-title":"Effectiveness of sleep-based interventions for children with autism spectrum disorder: a meta-synthesis","volume":"37","author":"Cuomo","year":"2017","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jaac.2017.09.414_bib15","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/j.1365-2869.2012.01021.x","article-title":"Controlled-release melatonin, singly and combined with cognitive behavioural therapy, for persistent insomnia in children with autism spectrum disorders: a randomized placebo-controlled trial","volume":"21","author":"Cortesi","year":"2012","journal-title":"J\u00a0Sleep Res"},{"key":"10.1016\/j.jaac.2017.09.414_bib16","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1007\/s10803-011-1418-3","article-title":"Melatonin for sleep in children with autism: a controlled trial examining dose, tolerability, and outcomes","volume":"42","author":"Malow","year":"2012","journal-title":"J\u00a0Autism Dev Disord"},{"key":"10.1016\/j.jaac.2017.09.414_bib17","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.pediatrneurol.2011.02.001","article-title":"Prolonged-release melatonin for children with neurodevelopmental disorders","volume":"45","author":"De Leersnyder","year":"2011","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.jaac.2017.09.414_bib18","unstructured":"European Medicines Agency. Circadin (melatonin). 2010. Available at: http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/medicines\/human\/medicines\/000695\/human_med_000701.jsp&mid=WC0b01ac058001d124. Accessed August 17,\u00a02017."},{"key":"10.1016\/j.jaac.2017.09.414_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics8010002","article-title":"Dissolution of intact, divided and crushed Circadin tablets: prolonged vs. immediate release of melatonin","volume":"8","author":"Chua","year":"2016","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jaac.2017.09.414_bib20","doi-asserted-by":"crossref","first-page":"e235","DOI":"10.1542\/peds.2008-2059","article-title":"Minitablets: new modality to deliver medicines to preschool-aged children","volume":"123","author":"Thomson","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaac.2017.09.414_bib21","doi-asserted-by":"crossref","first-page":"i-239","DOI":"10.3310\/hta16400","article-title":"The use of melatonin in children with neurodevelopmental disorders and impaired sleep: a randomised, double-blind, placebo-controlled, parallel study (MENDS)","volume":"16","author":"Appleton","year":"2012","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.jaac.2017.09.414_bib22","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1136\/adc.2002.017202","article-title":"The relative efficacy of two brief treatments for sleep problems in young learning disabled (mentally retarded) children: a randomised controlled trial","volume":"89","author":"Montgomery","year":"2004","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jaac.2017.09.414_bib23","doi-asserted-by":"crossref","first-page":"287","DOI":"10.5665\/sleep.1642","article-title":"The Consensus Sleep Diary: standardizing prospective sleep self-monitoring","volume":"35","author":"Carney","year":"2012","journal-title":"Sleep"},{"key":"10.1016\/j.jaac.2017.09.414_bib24","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1185\/03007995.2010.537317","article-title":"Prolonged release melatonin in the treatment of primary insomnia: evaluation of the age cut-off for short- and long-term response","volume":"27","author":"Wade","year":"2011","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jaac.2017.09.414_bib25","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/ajmg.c.30275","article-title":"Autism spectrum features in Smith-Magenis syndrome","volume":"154C","author":"Laje","year":"2010","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.1016\/j.jaac.2017.09.414_bib26","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1037\/0033-2909.112.1.155","article-title":"A\u00a0power primer","volume":"112","author":"Cohen","year":"1992","journal-title":"Psychol Bull"},{"key":"10.1016\/j.jaac.2017.09.414_bib27","unstructured":"Food and Drug Administration. Medical Review Application number 21-782. 2005. Available at: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2005\/021782s000_Rozerem_medr.pdf. Accessed August 17,\u00a02017."},{"key":"10.1016\/j.jaac.2017.09.414_bib28","unstructured":"Food and Drug Administration. Highlights of prescribing information Hetlioz R (tasimelteon). 2014. Available at: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2014\/205677s000lbl.pdf. Accessed August 17,\u00a02017."},{"key":"10.1016\/j.jaac.2017.09.414_bib29","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/00004850-199400940-00004","article-title":"Zopiclone improves sleep quality and daytime well-being in insomniac patients: comparison with triazolam, flunitrazepam and placebo","volume":"9","author":"Hajak","year":"1994","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.jaac.2017.09.414_bib30","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1365-2788.2010.01283.x","article-title":"Loss of response to melatonin treatment is associated with slow melatonin metabolism","volume":"54","author":"Braam","year":"2010","journal-title":"J\u00a0Intellect Disabil Res"}],"container-title":["Journal of the American Academy of Child &amp; Adolescent Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856717316726?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856717316726?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,27]],"date-time":"2018-08-27T10:35:19Z","timestamp":1535366119000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890856717316726"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S0890856717316726"],"URL":"https:\/\/doi.org\/10.1016\/j.jaac.2017.09.414","relation":{},"ISSN":["0890-8567"],"issn-type":[{"value":"0890-8567","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children With Autism Spectrum Disorder","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Child & Adolescent Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaac.2017.09.414","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a92017 American Academy of Child and Adolescent Psychiatry. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}